To investigate the personal financial impact of vestibular schwannoma (VS) management through a survey hosted by the Acoustic Neuroma Association (ANA).
✦ The floor
Discussion
Signed responses from readers of the wire.
Clinicians managing vestibular schwannoma patients should be aware of substantial personal financial burdens; while this study does not change treatment protocols, it supports integrating financial counseling or social-work referrals into care pathways.
Quantifying the financial toxicity of vestibular schwannoma management highlights an underaddressed patient-centered outcome that could influence shared decision-making and healthcare policy.
- 01Cross-sectional survey conducted through the Acoustic Neuroma Association patient registry.
- 02Study focuses on out-of-pocket and indirect financial costs of vestibular schwannoma care.
- 03Financial burden is an underreported outcome in neuro-otology and audiology literature.
- 04Findings may support the case for financial navigation services in multidisciplinary tumor teams.
- 05Published in the Journal of Neuro-Oncology (2026).
Patients with vestibular schwannoma experience measurable personal financial burden as a result of their management.
studypartially supported- PMID
- 42722776
- DOI
- 10.1007/s11060-026-05797-9.
- Journal
- Journal of Neuro-Oncology
- Publication type
- research_article
- Evidence level
- 4
- Population
- Patients with vestibular schwannoma recruited via the Acoustic Neuroma Association
- Intervention
- Cross-sectional survey assessing personal financial impact of vestibular schwannoma management
Primary outcomes
Personal financial burden (out-of-pocket costs and indirect costs) associated with vestibular schwannoma management